Versigent (NYSE:VGNT) Receives $45.11 Consensus PT from Analysts

Shares of Versigent (NYSE:VGNT) have been given a consensus rating of “Moderate Buy” by the eleven research firms that are covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $45.6667.

Several analysts have recently weighed in on the stock. Royal Bank Of Canada assumed coverage on shares of Versigent in a research report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 price objective for the company. Fox Advisors upgraded shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Zacks Research upgraded shares of Versigent to a “hold” rating in a research report on Thursday, April 16th. TD Cowen boosted their price objective on shares of Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Wolfe Research assumed coverage on shares of Versigent in a research report on Thursday, April 30th. They set an “outperform” rating and a $53.00 price objective for the company.

Versigent Stock Down 4.3%

Versigent stock opened at $42.54 on Wednesday. Versigent has a 1-year low of $26.34 and a 1-year high of $47.27.

Versigent (NYSE:VGNT) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $999.00 earnings per share for the quarter.